Capital Performance Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-46
Closed -$1.35K 2395
2024
Q3
$1.35K Buy
+46
New +$1.35K ﹤0.01% 1760